This week in vaccines
14th February 2016
The big news this week was all about vaccines as effective investments, as a new batch of research showed that for every US $1 invested in immunisation, $16-$44 was reaped in socio-economic benefits. This confirms previous thinking about vaccination as a “best buy” when it comes to health spending.
Against the growing problem of antimicrobial resistance, a commission based in the UK also recommended vaccines – both those already use and future products – as a tool to fight resistance to antibiotics.
Finally, more than a year on from the launch of inactivated polio vaccine in Nepal, The Lancet looked at the successes and challenges the vaccine has faced in South East Asia, while doctors in the US explored the final steps for global polio eradication.